The gap between what an oncologist means by palliative systemic therapy and what a patient hears is one of the best documented findings in the field, and it does not close on its own. Patients receiving treatment with no curative intent frequently believe it might cure them, and that belief is not corrected by the consultation in which the treatment was agreed.
It matters because every subsequent decision rests on it. A patient who believes cure is possible will accept toxicity that they would refuse for three months of disease control, will find a decision to stop incomprehensible, and will not be referred to palliative care until very late.
The question is simple and should be asked before the regimen is described, not after: what is your understanding of what this treatment can do for you. Then listen without correcting for a moment. The answer determines what the rest of the conversation has to be about, and it is very often not what the clinician assumed.
- Ask what the patient understands the treatment can achieve, before describing the regimen.
- Ask it again when the line of therapy changes; understanding drifts.
- Record the answer in the notes, so the next clinician knows what was understood.
- Distinguish explicitly between controlling the disease and curing it, in plain words.
- Involve the family member who will be present for the decision, not only the patient.
Why it matters
Every decision about toxicity, stopping and palliative care rests on an understanding that is frequently different from the one the clinician assumes.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for oncology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free